Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP208072.RAyJlf6HX_JPS_ajdFXcFUHPrwIAjKCJjly0LWNJeB_y8130_assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208072.RAyJlf6HX_JPS_ajdFXcFUHPrwIAjKCJjly0LWNJeB_y8130_provenance.
• NP866524.RAAX-Mp6jqOTV1qO1Z9G1QxthkZdXtuLi9GVTN2oU3ifc130_assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866524.RAAX-Mp6jqOTV1qO1Z9G1QxthkZdXtuLi9GVTN2oU3ifc130_provenance.
• NP713999.RAR0_C8i6fjKJ1yFgRItMJcjWh5PBNzxUOAbsQlcNQRwA130_assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713999.RAR0_C8i6fjKJ1yFgRItMJcjWh5PBNzxUOAbsQlcNQRwA130_provenance.
• NP714677.RAzQsKlwUh7_tjHakgWzDoOhpW42imN5WMTrh7hCe_fO8130_assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714677.RAzQsKlwUh7_tjHakgWzDoOhpW42imN5WMTrh7hCe_fO8130_provenance.
• NP866526.RAct0STXC7iWKc3KzT_y00pC6rDPgJXEV7JLuSQap6dSU130_assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866526.RAct0STXC7iWKc3KzT_y00pC6rDPgJXEV7JLuSQap6dSU130_provenance.
• assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP714060.RAqS_9E9UpNsVYWPcy9owaup22bFk_tzs2eKsA99drCLA130_assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714060.RAqS_9E9UpNsVYWPcy9owaup22bFk_tzs2eKsA99drCLA130_provenance.
• NP714685.RAts-7LxHBhY5ZZmj4uIdqq-HQKSZ7nEoFiUiFoovz2zc130_assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714685.RAts-7LxHBhY5ZZmj4uIdqq-HQKSZ7nEoFiUiFoovz2zc130_provenance.
• NP866520.RAjUUCGtk6kbcpFGmwQ2iRclgIwI8s8FEGwaZ9A6fiWf4130_assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866520.RAjUUCGtk6kbcpFGmwQ2iRclgIwI8s8FEGwaZ9A6fiWf4130_provenance.
• NP866521.RAq0FdHjQMjIgGCOYuwhMJyVs-bOytmfBV4RY5y-BoKIQ130_assertion description "[These data suggest that SSTR5 P335L is a hypofunctional protein with a potentially harmful effect on function, as well as potential latent effect, and therefore it could affect the clinical response to somatostatin analog therapy for patients with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866521.RAq0FdHjQMjIgGCOYuwhMJyVs-bOytmfBV4RY5y-BoKIQ130_provenance.